Kiromic Biopharma is an immuno-oncology, target discovery, and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. They are focused on extending the benefits of immunotherapy by leveraging DIAMOND AI (Kiromic Diamond Artificial Intelligence), which is a multi-purpose computational platform that can identify new cancer immunological targets for T-Cells and B-Cells.

Biotechnology

Kiromic Biopharma

Maurizio Chiriva-Internati

Lucia Piccotti

Sarah Madonna

Raquel Dien

Diane Duyen Nguyen

Brian Hungerford

Leonardo Mirandola

Trish Faulkner

Alan Guerrero

Scott Dahlbeck

The Scientific Research and Operations team at Kiromic Biopharma is responsible for driving the discovery and development of innovative cancer immunotherapies. This includes overseeing clinical trials, managing laboratory operations, ensuring good manufacturing practices (GMP), and leveraging AI-driven platforms like DIAMOND AI for identifying new immunological targets. The team also handles technical operations, quality assurance, and immune monitoring to support the therapeutic advancements in immuno-oncology.

Scientific Research and Operations

Scientific Advisory

Leadership Team

Scientific Research and Operations

About

Team members

Other teams at Kiromic Biopharma

Scientific Advisory

Leadership Team